Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-01-11
DOI
10.3389/fphar.2022.1014933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
- (2022) Rebecca Kristeleit et al. LANCET ONCOLOGY
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p
- (2021) Jianhui Liu et al. Cancer Cell International
- Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway
- (2021) Xiaoqing Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC
- (2021) Francesca Citron et al. EMBO Molecular Medicine
- New Cu(II) coordination polymer inhibits cervical cancer development by regulating BRCA1 protein via miR-9-5p
- (2021) Lin Zhang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells
- (2020) Zhi-hai Zheng et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13
- (2019) Lin Chen et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2
- (2019) Meng Shen et al. CANCER RESEARCH
- CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer
- (2019) Lei Zhang et al. Molecular Cancer
- Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
- (2017) Yumeng Wei et al. ONCOLOGY REPORTS
- Curcumin inhibits cancer progression through regulating expression of microRNAs
- (2017) Siying Zhou et al. TUMOR BIOLOGY
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer
- (2017) Bo Zhou et al. Frontiers of Medicine
- Curcumin: A new candidate for melanoma therapy?
- (2016) Hamed Mirzaei et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells
- (2016) Zeng Liu et al. Oncology Letters
- Combinational Treatment of Curcumin and Quercetin against Gastric Cancer MGC-803 Cells in Vitro
- (2015) Jian-Ye Zhang et al. MOLECULES
- Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells
- (2015) Lixia Wang et al. Oncotarget
- Induction of MicroRNA-9 Mediates Cytotoxicity of Curcumin Against SKOV3 Ovarian Cancer Cells
- (2014) Song-Feng Zhao et al. Asian Pacific Journal of Cancer Prevention
- Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression
- (2014) Can Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
- (2013) Chaoyang Sun et al. JNCI-Journal of the National Cancer Institute
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
- (2012) Subash C. Gupta et al. AAPS Journal
- Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance
- (2012) David J. Pinato et al. CANCER TREATMENT REVIEWS
- Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
- (2010) Murali M Yallapu et al. Journal of Ovarian Research
- Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
- (2009) Janice S. Kwon et al. JOURNAL OF CLINICAL ONCOLOGY
- Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells
- (2008) M. Sun et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation